| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Atypical onset of bicalutamide-induced liver injury
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Gee Young Yun, Seok Hyun Kim, Seok Won Kim, Jong Seok Joo, Ju Seok Kim, Eaum Seok Lee, Byung Seok Lee, Sun Hyoung Kang, Hee Seok Moon, Jae Kyu Sung, Heon Young Lee and Kyung Hee Kim |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Departments of Internal Medicine, Chungnam National University School of Medicine, Daejeon, South Korea |
|
|
| Corresponding Author |
Seok Hyun Kim, MD, PhD, Professor, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University Hospital, 266 Munhwa-ro, Daejeon 301-721, South Korea. midoctor@cnu.ac.kr |
| Key Words |
Bicalutamide; Drug-induced liver injury; Prostate neoplasm |
| Core Tip |
This case report describes a 62-year-old man with prostate cancer who experienced delayed liver injury after bicalutamide therapy. In previous case reports on bicalutamide-induced liver injury, liver failure occurred shortly after bicalutamide therapy initiation. However, in this case, liver injury occurred 5 mo after bicalutamide treatment initiation. Therefore, our case emphasizes that liver function measurements should be monitored from baseline for at least the first 6 mo of therapy, and then periodically during the entire period of treatment with bicalutamide.
|
| Publish Date |
2016-04-03 18:51 |
| Citation |
Yun GY, Kim SH, Kim SW, Joo JS, Kim JS, Lee ES, Lee BS, Kang SH, Moon HS, Sung JK, Lee HY, Kim KH. Atypical onset of bicalutamide-induced liver injury. World J Gastroenterol 2016; 22(15): 4062-4065 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i15/4062.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i15.4062 |
